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Imaging with [11C]-metformin in tumor bearing mice showed 
a large uptake in the kidneys and excretion through the 
bladder, as expected for metformin. An uptake of [11C]-
metformin was seen in both A549 (lung) and SiHa (cervix) 
tumors and autoradiography supported this finding. 
Biodistribution of metformin in humans is shown in figure 1 
with visible uptake in liver, kidney and the salivary glands, 
but no detectable uptake in brain, muscle or adipose tissue. 
 
Conclusion: It is possible to visualize distribution of [11C]-
metformin in vivo. In xenograft models uptake in tumor was 
seen. It will be of great interest to investigate whether it is 
possible to visualize an uptake in human tumors, which will 
be done in a planned study in prostate cancer patients. 
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Purpose or Objective: A high level of circulating osteopontin 
(OPN) at the end of radiotherapy (RT) is an adverse 
prognostic factor in patients with glioblastoma (GBM) and 
other tumours including rectum cancer. Recent mechanistic 
studies demonstrated HIF2α–mediated OPN/CD44 promotion 
of the glioma stem cell-like phenotype in a mouse model. 
Using unique paired tumour samples from patients with GBM, 
we investigated changes in levels of OPN protein expression 
following RT and compared these with rectum cancers from 
patients irradiated with the same pre-operative 
fractionation. 
 
Material and Methods: 3 patients with histologically 
confirmed GBM received pre-operative RT in an ethics-
approved Phase I trial. 2.5 Gy b.d. was delivered using IMRT 
over 5 days. Maximal safe tumour resection was performed at 
3, 5 and 10 days post RT in patients 1, 2 and 3 respectively. 
Immunohistochemistry was performed on the paired 
diagnostic biopsy and irradiated resection specimen using 
validated antibodies (rabbit polyclonal antibody to OPN: 
clone PA1-38332, Thermo Fisher Scientific) and an automated 
immunostainer. The staining was scored by a board-certified 
pathologist.  
 
Results: Levels of OPN in GBM tumour cells were high at 
baseline as compared with rectum adenocarcinoma. There 
was marked increase in OPN expression in response to RT in 
all three GBM tumours (Fig 1). Expression of Glut-1, a marker 
of intrinsic hypoxia and a target of HIF-2α, was not induced. 
Ki67 levels were reduced although levels of cyclin D1 
expression were unchanged. A dynamic contrast-enhanced 
(DCE) MRI performed on the last day of RT did not detect any 
change in tumour perfusion in any of the GBMs. Resection 
specimens from 3 rectum cancer patients irradiated 
preoperatively with the same schedule showed very low level 
induction of OPN. 
 
 
 
Conclusion: RT increased the levels of OPN expression in 
GBM tumour cells. This may be a direct effect or related to 
RT-induced changes in the hypoxic tumour microenvironment 
that were not detectable on a DCE-MRI or by Glut-1 
expression. Although RT significantly increases overall 
survival compared with surgery alone, particularly when 
combined with temozolomide, it may promote the cancer 
stem cell-like phenotype of residual GBM cells. Enhanced 
OPN/CD44 signalling in the perivascular niche is associated 
with resistance to therapy and blockade of this signalling 
pathway may prove of clinical benefit. The relative lack of 
induction of OPN expression in rectum cancer may explain 
the success of short course pre-operative RT in this tumour 
type. 
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Purpose or Objective: In process like reactive oxygen 
production and apoptosis mitochondria play an important role 
and both processes play also a significant role in radiotherapy 
(RT) response. Repair of RT induced damage is dependent on 
mitochondrial energy supply suggesting a role for 
mitochondrial DNA (mtDNA) in RT. mtDNA variations, such as 
mutations or depletion, might therefore influence RT 
response, as for example found in cisplatin-treated patients. 
Therefore carefully elucidating the effect of these processes 
in radiation response might be important. Hence, we 
hypothesize that reduced mitochondrial function enhances 
the radiation response as a consequence of reduced ATP 
production and increased cellular ROS exposure (Fig.1). 
